Glenn Shepard
@Suvretta Capital Management, Llc
Latest period2024 - Q3ReportedManaged Assets$3.125BTotal holdings98
Assets growth rate14.81%Assets growth rate (2-Q avg)7.96%Continuous growth in asset value4 quarters
Portfolio positions
This chart displays the top 10 holdings in Suvretta Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 98 positions.
Assets under management
The assets under management (AUM) of Suvretta Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.125B in assets, with a quarterly growth rate of 14.81% and a 2-quarter average growth rate of 7.96%. The portfolio is managed by Glenn Shepard, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
LVSLas Vegas Sands Corp
| 0.78% | $24.37M 484,110 shares@ $50.34 avg price | New Position |
PROKProkidney Corp
| 0.76% | $23.695M 12.341M shares@ $1.93 avg price | Increased 32.12% |
INTCIntel Corp
| 0.76% | $23.46M↑ Call 1M shares@ $23.46 avg price | New Position |
ABEOAbeona Therapeutics Inc
| 0.75% | $23.292M 3.686M shares@ $6.33 avg price | |
JNJJohnson & Johnson
| 0.72% | $22.437M 138,447 shares@ $162.07 avg price | Increased 53.67% |
BSXBoston Scientific Corp
| 0.68% | $21.092M 251,689 shares@ $83.8 avg price | |
PINSPinterest Inc
| 0.64% | $19.937M 615,911 shares@ $32.37 avg price | Increased 50.25% |
ZURAZura Bio Ltd
| 0.64% | $19.735M 4.861M shares@ $4.06 avg price | |
PEPGPepgen Inc
| 0.46% | $14.201M 1.661M shares@ $8.56 avg price | Increased 9.21% |
GLUEMonte Rosa Therapeutics Inc
| 0.46% | $14.093M 2.659M shares@ $5.3 avg price |